AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Global Lateral Epicondylitis Treatment Market Forecasts: 2019-2023 - Leading Players Are Bayer, GlaxoSmithKline, Johnson & Johnson Services, Merck Sharp & Dohme, and Pfizer - ResearchAndMarkets.com

February 20, 2019

DUBLIN--(BUSINESS WIRE)--Feb 20, 2019--The “Global Lateral Epicondylitis Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

Analysts have predicted that the lateral epicondylitis treatment market will register a CAGR of over 3% by 2023.

Various government and non-government organizations are initiating certain programs to increase awareness among people and avoid delays in diagnosis. Hence, an increase in the number of organizations and institutes that raise awareness among people about lateral epicondylitis is expected to drive the growth of the global lateral epicondylitis treatment market during the forecast period.

Growing prevalence of risk factors for lateral epicondylitis

The growing prevalence of these medical conditions is the major risk factor for the development of lateral epicondylitis. The increase in the number of patients with these diseases may develop lateral epicondylitis. This, in turn, is expected to aid in the use of available treatments and anticipated treatments and drive the growth of the global lateral epicondylitis treatment market during the forecast period.

Lack of approved treatment

Lateral epicondylitis is a common problem with many available treatment options, but largely recommended treatment option is the combination of corticosteroids, physiotherapy, and bracing. However, there is no approved treatment for lateral epicondylitis. Therefore, the lack of approved treatments in the market for lateral epicondylitis is expected to hamper the growth of the global lateral epicondylitis treatment market during the forecast period.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

Key Players

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY TYPE

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

PART 12: VENDOR ANALYSIS

For more information about this report visit https://www.researchandmarkets.com/research/8266kg/global_lateral?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190220005768/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Musculoskeletal Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/20/2019 12:47 PM/DISC: 02/20/2019 12:47 PM

http://www.businesswire.com/news/home/20190220005768/en